Trials / Unknown
UnknownNCT00535548
Hematopoietic Stem Cell Therapy in Chronic Wounds Using a Pressure Sore Model
Effect of Hematopoietic Stem Cells in Chronic Wounds Using a Pressure Sore Model: A Pilot Study on Feasibility, Safety and Potential Effects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Aim of the study: Evaluation of feasibility, safety and potential effects of stem cells on chronic wounds using a pressure sore model. Clinical relevance: * Accelerated healing of uncomplicated wounds * Enhanced healing of complicated (chronic, non-healing) wounds Study design: * Prospective controlled phase I/II study * Cohort of 5 patients in pilot study, then reevaluation Patients: \- Para- and tetraplegic patients with sacral pressure sores grade III-IVA according to the classification of Daniel and Seiler Methods: 1\. First surgical intervention: * Radical debridement of pressure sore * Bone marrow harvest from the iliac crest * Isolation of hematopoietic stem cells, aiming to gain \> 1 mio. CD 34+ cells per patient under GMP conditions 3\. Stem cell therapy (after 2 days) * Injection of stem cells in suspension (50'000 CD 34+ cells in 100 microliter saline per cm2 of wound surface) on one half of the total wound surface and cell-free saline on the other half as a control 4\. Second surgical intervention (after 3-4 weeks): * Complete excision of the wound * Closure of the defect by fasciocutaneous flap 5\. Evaluation of wound healing: * Clinical * 3D laser imaging * Histology * Growth factor assay
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Stem cell therapy | Injection of a hematopoietic stem cell suspension (50'000 CD 34+ cells per microliter) into the wound (1 microliter per cm2 of wound surface) |
Timeline
- Start date
- 2007-01-01
- Completion
- 2007-12-01
- First posted
- 2007-09-26
- Last updated
- 2007-09-26
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00535548. Inclusion in this directory is not an endorsement.